RO.CH

325.6

+0.74%↑

NOVN.CH

114.35

+0.5%↑

LONN.CH

486.25

+1.18%↑

SDZ.CH

64.85

+2.59%↑

STMN.CH

83.44

-4.2%↓

RO.CH

325.6

+0.74%↑

NOVN.CH

114.35

+0.5%↑

LONN.CH

486.25

+1.18%↑

SDZ.CH

64.85

+2.59%↑

STMN.CH

83.44

-4.2%↓

RO.CH

325.6

+0.74%↑

NOVN.CH

114.35

+0.5%↑

LONN.CH

486.25

+1.18%↑

SDZ.CH

64.85

+2.59%↑

STMN.CH

83.44

-4.2%↓

RO.CH

325.6

+0.74%↑

NOVN.CH

114.35

+0.5%↑

LONN.CH

486.25

+1.18%↑

SDZ.CH

64.85

+2.59%↑

STMN.CH

83.44

-4.2%↓

RO.CH

325.6

+0.74%↑

NOVN.CH

114.35

+0.5%↑

LONN.CH

486.25

+1.18%↑

SDZ.CH

64.85

+2.59%↑

STMN.CH

83.44

-4.2%↓

Home・Stock List・Bachem Holding AG

Search

Bachem Holding AG

Open

SectorHealthcare

73.75 0.75

Overview

Share price change

24h

Current

Min

72.95

Max

77.52

Key metrics
By Trading Economics
Income	49M 99M
Sales	69M 382M
P/E Sector Avg	34.293 67.147
EPS	1.317
Dividend yield	1.31
Profit margin	25.83
Employees	2,130
EBITDA	35M 107M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+18.93% upside

Dividends
By Dow Jones
Dividend yield Sector Avg	1.31% 2.36%
Next Earnings	30 Jul 2026

Market Stats
By TradingEconomics
Market Cap	1B 5.1B
Previous open	73
Previous close	73.75

News Sentiment

By Acuity

50%

50%

176 / 347 Healthcare

Bachem Holding AG Chart

Past performance is not a reliable indicator of future results.

Related News

4 May 2026, 22:17 UTC

Earnings

Australia's Westpac Lifts Dividend as 1st Half Profit Rises 2.7%

4 May 2026, 23:47 UTC

Earnings

Grab Holdings 1Q Adj EBITDA $154.0M Vs. $106.0M >GRAB

4 May 2026, 23:45 UTC

Earnings

Grab Holdings 1Q Rev $955.0M Vs. $773.0M >GRAB

4 May 2026, 23:45 UTC

Earnings

Grab Holdings 1Q Net $120.0M Vs. Net $10.0M >GRAB

4 May 2026, 23:40 UTC

Market Talk

Gold Steady Amid Likely Technical Recovery -- Market Talk

4 May 2026, 22:44 UTC

Acquisitions, Mergers, Takeovers

Regis: Jim Beyer To Be Chief Executive of Combined Company

4 May 2026, 22:43 UTC

Acquisitions, Mergers, Takeovers

Regis: Russell Clark To Be Nonexecutive Chairman of Combined Company

4 May 2026, 22:42 UTC

Acquisitions, Mergers, Takeovers

Regis: Companies Expect to Realize Over A$500 Million in Corporate Tax Benefits

4 May 2026, 22:42 UTC

Acquisitions, Mergers, Takeovers

Regis: Combined Company to Have Strong, Debt-Free Balance Sheet; Significant Cash Generation

4 May 2026, 22:41 UTC

Acquisitions, Mergers, Takeovers

Regis: Combined Company to Have Annual Production of More Than 700,000 Oz

4 May 2026, 22:41 UTC

Acquisitions, Mergers, Takeovers

Regis: Pro Forma Market Capitalization About A$10.7 Billion

4 May 2026, 22:40 UTC

Acquisitions, Mergers, Takeovers

Regis: Shareholders to Own About 51% of Combined Company

4 May 2026, 22:40 UTC

Acquisitions, Mergers, Takeovers

Regis: Board Unanimously Endorsed, Supported Deal

4 May 2026, 22:40 UTC

Acquisitions, Mergers, Takeovers

Regis: Deal Unanimously Recommended by Vault Board

4 May 2026, 22:39 UTC

Acquisitions, Mergers, Takeovers

Regis: Vault Shareholders to Receive 0.6947 New Shares in Regis For Each Vault One Held

4 May 2026, 22:38 UTC

Acquisitions, Mergers, Takeovers

Regis Resources to Acquire All Ordinary Shares in Vault

4 May 2026, 22:38 UTC

Acquisitions, Mergers, Takeovers

Regis Resources, Vault Minerals Agree to Merger of Equals

4 May 2026, 22:37 UTC

Earnings

Acquisitions, Mergers, Takeovers

Palantir Beats Forecasts With $1.63 Billion Quarter as Sales Accelerate -- 2nd Update

4 May 2026, 22:26 UTC

Earnings

Acquisitions, Mergers, Takeovers

Palantir Beats Forecasts With $1.63 Billion Quarter as Sales Accelerate -- Update

4 May 2026, 22:02 UTC

Earnings

Australia's Westpac Lifts Dividend as 1H Profit Rises 2.7%

4 May 2026, 22:00 UTC

Market Talk

BOC's Macklem: Conditions To Dictate Fuel-Price Response -- Market Talk

4 May 2026, 21:52 UTC

Earnings

Westpac 1H Net Profit Ex-Notable Items A$3.48B Vs. A$3.46B>WBC.AU

4 May 2026, 21:50 UTC

Earnings

Westpac: Some Sectors More Affected Than Others>WBC.AU

4 May 2026, 21:50 UTC

Earnings

Westpac: Economic Impact of Middle East Conflict to Continue Through Year>WBC.AU

4 May 2026, 21:49 UTC

Earnings

Westpac 1H Provision for Expected Credit Losses A$4.68B Vs. A$4.58B>WBC.AU

4 May 2026, 21:44 UTC

Earnings

Westpac 1H Australia Lending Up 8% on Year>WBC.AU

4 May 2026, 21:44 UTC

Earnings

Westpac 1H Australia Business Lending Up 16% on Year>WBC.AU

4 May 2026, 21:43 UTC

Earnings

Westpac 1H Core Net Interest Margin 1.78% Vs. 1.80%>WBC.AU

4 May 2026, 21:41 UTC

Earnings

Westpac 1H Australian Home Lending Up 7% on Year Excluding RAMS Portfolio>WBC.AU

4 May 2026, 21:40 UTC

Earnings

Westpac 1H Credit Impairment Charge 10 Bps of Average Loans Vs. 6 Bps>WBC.AU

Peer Comparison

Price change

Bachem Holding AG Forecast

Price Target

By TipRanks

18.93% upside

12 Months Forecast

Average 84.2 CHF 18.93%

High 110 CHF

Low 65 CHF

Based on 5 Wall Street analysts offering 12 month price targets forBachem Holding AG - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

5 ratings

4

Buy

1

Hold

0

Sell

Based on 5 analysts giving stock ratings to Bachem Holding AG - Dist in the past 3 months.

Sentiment

By Acuity

176 / 347 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Bachem Holding AG

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was founded in 1971 and is headquartered in Bubendorf, Switzerland.

Other stocks from the sector

RO.CH

Roche Holding AG

325.6

NOVN.CH

Novartis AG

114.35

LONN.CH

Lonza Group AG

486.25

SDZ.CH

Sandoz Group AG

64.85

STMN.CH

Straumann Holding AG

83.44

Live chat